MedPath

Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions

Not Applicable
Completed
Conditions
Dental Hypersensitivity
Registration Number
NCT04642001
Lead Sponsor
Universidade Federal do Para
Brief Summary

This randomized, double-blind clinical trial evaluated the effect of photobimodulation associated with 8% strontium acetate in the treatment of dentin hypersensitivity in non-carious lesions and analyzed the risk factors with the patient's quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Age between 18 to 50 years
  • Good general health
  • Dental sensitivity with response ≥ 4 on the 10 cm long visual analog scale (EVA)
  • Presence of at least two hypersensitive teeth with a depth of up to 1 mm (measured with a millimeter probe)
  • Exposed root surface caused by abrasion, erosion or gum recession
Exclusion Criteria
  • Volunteers using analgesic medication
  • Presence of teeth with evidence of carious lesions, pulpitis, defective restorations and moderate or severe periodontal disease
  • Patients who had undergone any whitening therapy or professional or homemade desensitizer in the last six months
  • Patient with fixed orthodontic appliances
  • Drug users or pregnant women were also excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
dentin sensitivity30 days after the end of treatment

evaluation of dentinal sensitivity during treatment and one month after its end, by means of tactile and evaporative stimuli according to the visual analog scale with values from 0 to 10, with higher values indicating a worse level of pain.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universidade Federal do Pará

🇧🇷

Belém, Pará, Brazil

Universidade Federal do Pará
🇧🇷Belém, Pará, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.